1. Lidia Staszewsky, Laura Cortesi, Marta Baviera, Mauro Tettamanti, Irene Marzona, Alessandro Nobili, et al. Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy. Diabetes Res Clin Pract. 2015;109(3):476-84.
2. Marie J Béland, Kevin C Harris, Ariane J Marelli, Lucile Houyel, Frédérique Bailliard, Frédéric Dallaire, et al. Improving Quality of Congenital Heart Disease Research in Canada: Standardizing Nomenclature Across Canada. Can J Cardiol. 2018;34(12):1674-1676.
3. Jannik L Pallisgaard, Anne-Marie Schjerning, Tommi B Lindhardt, Kristina Procida, Morten L Hansen, Christian Torp-Pedersen, et al. Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study. Eur J Prev Cardiol. 2016;23(6):621-7.
4. Andy Menke, Sarah Casagrande, Linda Geiss, Catherine C Cowie. Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. JAMA. 2015;314(10):1021-9.
5. Shilpa N Bhupathiraju, Frank B Hu. Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications. Circ Res. 2016;118(11):1723-35.
6. NikolasWanahita, Franz H.Messerli, SripalBangalore, Apoor S.Gami, Virend K.Somers, Jonathan S.Steinberg, et al. Atrial fibrillation and obesity—results of a meta-analysis. Am Heart J. 2008;155(2):310-5.
7. Usha B Tedrow, David Conen, Paul M Ridker, Nancy R Cook, Bruce A Koplan, Joann E Manson, Julie E Buring, et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). J Am Coll Cardiol. 2010;55(21):2319-27.
8. Thomas J Wang, Helen Parise, Daniel Levy, Ralph B D'Agostino Sr, Philip A Wolf, Ramachandran S Vasan, Emelia J Benjamin. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004 Nov 24;292(20):2471-7.
9. Anat Berkovitch, Shaye Kivity, Robert Klempfner, Shlomo Segev, Assi Milwidsky, Aharon Erez, et al. Body mass index and the risk of new-onset atrial fibrillation in middle-aged adults. Am Heart J. 2016 Mar;173:41-8.
10. Yun Gi Kim, Kyung-Do Han, Jong-Il Choi, Ki Yung Boo, Do Young Kim, Suk-Kyu Oh, et al. The impact of body weight and diabetes on new-onset atrial fibrillation: a nationwide population based study. Cardiovasc Diabetol. 2019;18(1):128.
11. Lee JW, Brancati FL, Yeh HC. Trends in the prevalence of type 2 diabetes in asians versus whites: Results from the united states national health interview survey, 1997–2008. Diabetes care. 2011; 34:353–357.
12. Unjali P Gujral, Viswanathan Mohan, Rajendra Pradeepa, Mohan Deepa, Ranjit Mohan Anjana, K M Narayan. Ethnic differences in the prevalence of diabetes in underweight and normal weight individuals: The CARRS and NHANES studies. Diabetes Res Clin Pract. 2018 Dec;146:34-40.
13. Loic Desquilbet, François Mariotti, et al. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010 Apr 30;29(9):1037-57.
14. Chrishan Joseph Nalliah, Prashanthan Sanders, Hans Kottkamp, Jonathan M Kalman. The role of obesity in atrial fibrillation. Eur Heart J. 2016;37(20):1565-72.
15. Jedrzej Kosiuk, Yves Van Belle, Kerstin Bode, Jelena Kornej, Arash Arya, Sascha Rolf, et al. Left ventricular diastolic dysfunction in atrial fibrillation: predictors and relation with symptom severity. J Cardiovasc Electrophysiol. 2012;23(10):1073-7.
16. Thomas M Munger, Ying-Xue Dong, Mitsuru Masaki, Jae K Oh, Sunil V Mankad, Barry A Borlaug, et al. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. J Am Coll Cardiol. 2012;60(9):851-60.
17. Hany S Abed, Gary A Wittert, Darryl P Leong, Masoumeh G Shirazi, Bobak Bahrami, Melissa E Middeldorp, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013;310(19):2050-60.
18. Rajeev K Pathak, Melissa E Middeldorp, Megan Meredith, Abhinav B Mehta, Rajiv Mahajan, Christopher X Wong, et al. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159-69.
19. Rajiv Mahajan, Dennis H Lau, Anthony G Brooks, Nicholas J Shipp, John P M Wood, Jim Manavis, et al. Atrial Fibrillation and Obesity: Reverse Remodeling of Atrial Substrate With Weight Reduction. JACC Clin Electrophysiol. 2021;7(5):630-641.
20. Andrew Elagizi, Sergey Kachur, Carl J Lavie, Salvatore Carbone, Ambarish Pandey, Francisco B Ortega, et al. An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases. Prog Cardiovasc Dis. Jul-Aug 2018;61(2):142-150.
21. Krishnan Bhaskaran, Isabel Dos-Santos-Silva, David A Leon, Ian J Douglas, Liam Smeeth. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6(12):944-953.
22. Si-Hyuck Kang, Eue-Keun Choi, Kyung-Do Han, So-Ryoung Lee, Woo-Hyun Lim, Myung-Jin Cha, et al. Underweight is a risk factor for atrial fibrillation: A nationwide population-based study. Int J Cardiol. 2016 Jul 15;215:449-56.
23. Hai Deng, Alena Shantsila, Pi Guo, Tatjana S Potpara, Xianzhang Zhan, Xianhong Fang, et al. A U-shaped relationship of body mass index on atrial fibrillation recurrence post ablation: A report from the Guangzhou atrial fibrillation ablation registry. EBioMedicine. 2018;35:40-45.
24. Wolfram Doehner, Hertzel C Gerstein, Janina Ried, Hyejung Jung, Christian Asbrand, Sibylle Hess, et al. Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial. Eur Heart J. 2020 Jul 21;41(28):2668-2677.
25. Yeongkeun Kwon, Hyun Jung Kim, Sungsoo Park, Yong-Gyu Park, Kyung-Hwan Cho. Body Mass Index-Related Mortality in Patients with Type 2 Diabetes and Heterogeneity in Obesity Paradox Studies: A Dose-Response Meta-Analysis. PLoS One. 2017 Jan 3;12(1):e0168247.
26. Vojtech Hainer, Irena Aldhoon-Hainerová. Obesity paradox does exist. Diabetes Care. 2013 Aug;36 Suppl 2(Suppl 2):S276-81.
27. Murray Esler, Gavin Lambert, Markus Schlaich, John Dixon, Carolina Ika Sari, Elisabeth Lambert. Obesity Paradox in Hypertension: Is This Because Sympathetic Activation in Obesity-Hypertension Takes a Benign Form? Hypertension. 2018;71(1):22-33.
28. Nathalie Eckel, Kristin Mühlenbruch, Karina Meidtner, Heiner Boeing, Norbert Stefan, Matthias B Schulze. Characterization of metabolically unhealthy normal-weight individuals: Risk factors and their associations with type 2 diabetes. Metabolism. 2015 Aug;64(8):862-71.
29. Unjali P Gujral, K M Venkat Narayan. Diabetes in Normal-Weight Individuals: High Susceptibility in Nonwhite Populations. Diabetes Care. 2019 Dec;42(12):2164-2166.
30. Salvatore Carbone, Carl J Lavie. An opposing point of view on the obesity paradox. Postgrad Med. 2019 Jun;131(5):333-334.
31. Yong-Soo Baek, Pil-Sung Yang, Tae-Hoon Kim, Jae-Sun Uhm, Junbeom Park, Hui-Nam Pak, et al. Associations of Abdominal Obesity and New-Onset Atrial Fibrillation in the General Population. J Am Heart Assoc. 2017 Jun 6;6(6):e004705.
32. Francisco B Ortega, Xuemei Sui, Carl J Lavie, Steven N Blair. Body Mass Index, the Most Widely Used But Also Widely Criticized Index: Would a Criterion Standard Measure of Total Body Fat Be a Better Predictor of Cardiovascular Disease Mortality? Mayo Clin Proc. 2016 Apr;91(4):443-55.
33. Wen-Yuan Lin, Shin-Li Tsai, Jeanine B Albu, Cheng-Chieh Lin, Tsai-Chung Li, F Xavier Pi-Sunyer, Pei-Kun Sung, et al. Body mass index and all-cause mortality in a large Chinese cohort. CMAJ. 2011 Apr 5;183(6):E329-36.